Advertisement

Topics

Ipragliflozin beneficial in T2DM complicated by liver disease

11:00 EDT 3 Aug 2017 | Medical Xpress

(HealthDay)—For patients with type 2 diabetes and nonalcoholic fatty liver disease (NAFLD), ipragliflozin exerts beneficial effects on NAFLD and glycemic control, similar to pioglitazone, according to a study published online July 27 in Diabetes Care.

Original Article: Ipragliflozin beneficial in T2DM complicated by liver disease

NEXT ARTICLE

More From BioPortfolio on "Ipragliflozin beneficial in T2DM complicated by liver disease"

Quick Search
Advertisement
 

Relevant Topic

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...